✦ LIBER ✦

6048 A comparison of efficacy of first-line chemotherapy regimens for metastatic colorectal cancer (mCRC): FOLFIRI+ bevacizumab vs. XELIRI+ bevacizumab

✍ Scribed by Ocvirk, J.; Rebersek, M.; Boc, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6084 Efficacy and safety of bevacizumab-

✍ Ducreux, M.; Adenis, A.; Pignon, J.P.; François, E.; Chauffert, B.; Boucher, E.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Safety and efficacy of first-line bevaci

✍ Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolome 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 201 KB

6115 VEGF gene polymorphisms in the pred

✍ Loupakis, F.; Ruzzo, A.; Salvatore, L.; Canestrari, E.; Cremolini, C.; Santini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

616 POSTER Safety analysis of first-line

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A retrospective observational study on t

✍ López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB

6132 POSTER Efficacy of Panitumumab Plus

✍ Price, T.; Peeters, M.; Strickland, A.; Ciuleanu, T.E.; Scheithauer, W.; O'Reill 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB